OFI Advisors’s Celgene Corp CELG Stock Holding History

OFI Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$627K	Sell	5,792 -592	-9%	-$73.5K	0.04%	572
2015 Q2	$739K	Sell	6,384 -45	-0.7%	-$5.14K	0.04%	535
2015 Q1	$741K	Buy	6,429 +1,183	+23%	+$141K	0.04%	524
2014 Q4	$587K	Sell	5,246 -706	-12%	-$74.5K	0.04%	603
2014 Q3	$564K	Sell	5,952 -152	-2%	-$13.7K	0.04%	556
2014 Q2	$524K	Buy	6,104 +4	+0.1%	+$304	0.04%	609
2014 Q1	$426K	Buy	6,100 +1,042	+21%	+$82.5K	0.03%	673
2013 Q4	$427K	Buy	5,058 +124	+3%	+$9.81K	0.03%	643
2013 Q3	$380K	Sell	4,934 -930	-16%	-$65.2K	0.04%	592
2013 Q2	$343K	Buy	+5,864	New	+$353K	0.04%	568

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OFI Advisors's CELG Position: Q3 2015 in Review

OFI Advisors reduced its Celgene Corp (CELG) stake by 9.3% in Q3 2015, selling an estimated $73.5K and leaving 5,792 shares worth $627K. The position accounts for 0.04% of the portfolio, ranked #572.

OFI Advisors first reported a position in CELG in Q2 2013 and has held it in 10 quarters since. The position peaked at $741K in Q1 2015. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

OFI Advisors held 5,792 shares of Celgene Corp worth $627K as of Q3 2015.
OFI Advisors sold 592 Celgene Corp shares in Q3 2015, an estimated $73.5K.
Celgene Corp made up 0.04% of OFI Advisors's portfolio in Q3 2015, its #572 holding.
OFI Advisors first reported a position in Celgene Corp in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Celgene Corp position peaked at $741K in Q1 2015.
1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.